| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |